An angiographic study of intracoronary streptokinase versus intravenous tissue plasminogen activator after failed coronary thrombolysis with intravenous streptokinase

Journal of Thrombosis and Thrombolysis

Volumn 3, Issue 3, 1996, Pages 239-243

  Verheugt, Freek W A ^a,b   Veen, Gerrit ^a   De Cock, Carel C ^a   Meijer, Albert ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Failure; Intracoronary streptokinase; Intravenous streptokinase; Tissue plasminogen activator

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CATHETERIZATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CORONARY ARTERY THROMBOSIS; DEATH; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HUMAN; INTRACARDIAC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYMPTOM; TREATMENT FAILURE;

EID: 0029758194     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00181666     Document Type: Article

References (22)

1. Verstraete M. Thrombolytic therapy in acute myocardial infarction. Circulation 1990;82(Suppl II):II96-II109.
2. Zijlstra F, De Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-684.
3. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-679.
4. GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;22: 1615-1622.
5. Verstraete M, Bory M, Collen D, et al. Double blind trial of intravenous tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Lancet 1985;1:842-847.
6. GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
7. White HD, Cross DB, Williams BF, et al. "Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intracoronary thrombolysis with streptokinase for acute myocardial infarction. Am J Cardiol 1995;75:172-174.
8. Mounsey JP, Skinner JE, Hawkins TE, et al. rt-PA after failed reperfusion with streptokinase in acute myocardial infarction: A prospective randomised trial (abstr). Circulation 1993;88(Suppl I):491.
9. Barbash GI. Rescue thrombolysis in reinfarction (abstr). Circulation 1993;88(Suppl I):491.
10. Barbash GI, Ohman EM, White HD, Granger C, Califf RM. Rescue thrombolysis for suspected reinfarction following thrombolytic therapy: Experience from the GUSTO trial (abstr). J Am Coll Cardiol 1994;23:29A.
11. Meijer A, Verheugt PWA, Werter CJPJ, et al. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: A prospective placebo-controlled angiographic study. Results of the APRICOT Study. Circulation 1993;87:1524-1530.
12. Neuhaus KL, Feuerer W, Jeep-Tebbe S, Niederer W, Vogt A, Tebbe U. Improved thrombolysis with a modified dose regimen of recombinant tissue type plasminogen activator. J Am Coll Cardiol 1989;14:1566-1569.
13. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987;76:142-154.
14. Lynch M, Littler WA, Pentecost BL, Stockley RA. Immunoglobulin response to intravenous streptokinase in acute myocardial infarction. Br Heart J 1991;66:139-142.
15. Buchalter MB, Suntharalingam G, Jennings I, et al. Streptokinase resistance: When might streptokinase administration be ineffective? Br Heart J 1992;68:449-453.
16. Lee HS, Cross S, Davidson R, Reid T, Jennings K. Raised levels of antistreptokinase antibody and neutralization titres from 4 days to 54 months after administration of streptokinase or anistreplase. Eur Heart J 1993;14:84-89.
17. LATE Study Group. Late assessment of thrombolytic efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993;342:759-766.
18. EMERAS Collaborative Group. Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet 1993;342:767-772.
19. Ellis SG, Ribeiro da Silva E, Heyndrickx GR, et al. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 1994;90:2280-2284.
20. Califf RM, Topol EJ, George BS, et al. Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial. Circulation 1988;77:1090-1099.
21. White HD, Cross DB, Elliott JM, Norris R, Yee TW. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation 1994;89:61-67.
22. Simoons ML, Vos J, Tijssen JGP, et al. Long term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 years follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands. J Am Coll Cardiol 1989;14:1609-1615.